CD74 and CD44 Expression on CTCs in Cancer Patients with Brain Metastasis

Up to 40% of advance lung, melanoma and breast cancer patients suffer from brain metastases (BM) with increasing incidence. Here, we assessed whether circulating tumor cells (CTCs) in peripheral blood can serve as a disease surrogate, focusing on CD44 and CD74 expression as prognostic markers for BM...

Descripción completa

Detalles Bibliográficos
Autores principales: Loreth, Desiree, Schuette, Moritz, Zinke, Jenny, Mohme, Malte, Piffko, Andras, Schneegans, Svenja, Stadler, Julia, Janning, Melanie, Loges, Sonja, Joosse, Simon A., Lamszus, Katrin, Westphal, Manfred, Müller, Volkmar, Glatzel, Markus, Matschke, Jakob, Gebhardt, Christoffer, Schneider, Stefan W., Belczacka, Iwona, Volkmer, Beate, Greinert, Rüdiger, Yaspo, Marie-Laure, Harter, Patrick N., Pantel, Klaus, Wikman, Harriet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268634/
https://www.ncbi.nlm.nih.gov/pubmed/34209696
http://dx.doi.org/10.3390/ijms22136993

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268634/
https://www.ncbi.nlm.nih.gov/pubmed/34209696
http://dx.doi.org/10.3390/ijms22136993

Ejemplares similares